Merkley, Wyden, Colleagues Reintroduce Updated DISCLOSE Act to End Corrupting Influence of Dark Money in American Elections
185 Democrats support effort to empower voters and expose billionaire and special interest control over our government and courts Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden joined a bicameral group of Democrats in reintroducing the DISCLOSE Act, legislation to shine a bright light of transparency on the scourge of dark money in politics and make government more
Ranking Members Heinrich and Merkley Demand Answers from Trump Administration on Efforts to Erase History on Public Lands
Washington, D.C. — U.S. Senators Martin Heinrich (D-N.M.), Ranking Member of the U.S. Senate Energy and Natural Resources Committee, and Jeff Merkley (D-Ore.), Ranking Member of the U.S. Appropriations Subcommittee on Interior, Environment, and Related Agencies, sent a letter to the U.S. Department of the Interior (DOI) demanding answers from the National Park Service (NPS) following reports that
Merkley Investigates Chemical Industry Insiders Taking Over Critical EPA Chemical Safety Office
Washington, D.C. – Oregon’s U.S. Senator Jeff Merkley—the top Democrat on the Senate Environment and Public Works (EPW) subcommittee overseeing environmental justice, chemical safety, and waste management—today sent an oversight letter following reports of former chemical industry lobbyists filling key positions at the Environmental Protection Agency’s (EPA) Office of Chemical
Merkley, Wyden Announce Over $6.5 Million in Transit Grants for Oregon
Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today announced that the Lane Transit and Rogue Valley Transportation Districts will receive $3,952,851, and $2,687,000, respectively, in federal grants to support critical bus and bus facility upgrades. The Rogue Valley Transportation District’s grant will help replace, rehabilitate, and purchase
Merkley, Wyden Announce Over $7 Million to Help First-Generation, Low-Income Students, and Students with Disabilities Succeed in College
Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today announced that over $7 million in TRIO grants are headed to 19 higher education institutions across Oregon to support first-generation, low-income students, and students with disabilities through the Student Support Services Program. Students who receive the grant will have
Merkley Continues Push for Expanded Work Share Provisions in Next Relief Package
WASHINGTON – Oregon’s U.S. Senator Jeff Merkley is pushing Senate leadership today to include ideas from his legislation, the Rebuilding Main Street Act, within the next relief package. The Rebuilding Main Street Act would incentivize and expand the use of the Work Share program, which allows businesses and nonprofits to
Wyden, Merkley Join Colleagues to Introduce Comprehensive Legislation to Help Achieve Environmental Justice for All
Washington, D.C. – Oregon’s U.S. Sens. Ron Wyden and Jeff Merkley recently joined U.S. Sens. Kamala D. Harris, D-Calif., Cory Booker, D-N.J., and Tammy Duckworth, D-Ill., to introduce the Environmental Justice for All Act to improve health equity and climate justice for all, particularly underserved communities and communities of color. As the nation reckons with systemic racism, the
Merkley, Wyden Introduce Resolution Celebrating the 55th Anniversary of the Voting Rights Act of 1965
WASHINGTON – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden today introduced a Senate Resolution to recognize, commemorate, and celebrate the 55th anniversary of the enactment of the landmark Voting Rights Act of 1965. President Lyndon Johnson proposed the legislation just days after the civil rights march from Selma to
Merkley, Smith Unveil Plan to Prevent Pharmaceutical Companies from Price Gouging COVID-19 Vaccines, Treatments
WASHINGTON, D.C. – Oregon’s U.S. Senator Jeff Merkley continued his leadership in tackling pharmaceutical companies’ price gouging by teaming up with U.S. Senator Tina Smith (D-MN) today to introduce legislation to ensure that any taxpayer-funded vaccine or treatment for coronavirus (COVID-19) proven to be safe and effective will be accessible,